NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2019, Vol. 31 ›› Issue (3): 422-427. doi: 10.16333/j.1001-6880.2019.3.008

Special Issue: No.4

• Article • Previous Articles     Next Articles

Effect of berberine on the proliferation of breast cancer MDA-MB-231 cells and its molecular mechanism

QIAN Jie1,2,TAN Jia-ni1,3,CHENG Hai-bo1,3,SHEN Wei-xing1,XU Chang-liang1,LIU Tao-shi2*,SUN Dong-dong1,3*   

  1. 1Translational Medicine Center of Nanjing University of Chinese Medicine,Key Laboratory of Famous Doctors' Proved Recipe Evaluation and Transformation of State Administration of Traditional Chinese Medicine,Provincial Lab of Anticarcinoma Proved Recipe Research and Engineering Industrialization; 2College of Pharmacy,Nanjing University of Chinese Medicine; 3Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor,Nanjing 210023,China
  • Online:2019-04-02 Published:2019-04-02

Abstract: This study aims to explore the effect of berberine on the proliferation of breast cancer MDA-MB-231 cells and to explain the molecular mechanism of berberine promoting apoptosis in breast cancer cells.During the experiment,MTT was used to detect the inhibitory effect of berberine on the proliferation of breast cancer MDA-MB-231 cells.Then,Annexin-V/PI staining was used to quantitatively investigate the effect of berberine on tumor cell apoptosis.Finally,Western Blot assay was used to detect tumor-associated pathway protein expression for study.The results showed that berberine inhibited the proliferation of breast cancer MDA-MB-231 cells,which increased the expression of autophagy factor Beclin 1 in the cells.Further,the formation of autophagic vacuoles was induced,resulting in apoptosis of tumor cells.In summary,berberine exerted anti-tumor effects by inhibiting autophagy and apoptosis of MDA-MB-231 cells by inhibiting the AKT-mTOR pathway.

Key words: berberine, breast cancer, antitumor, autophagy, AKT-mTOR pathway

CLC Number: